,B (DLBCL)

Ruixin Sun1, Pengcheng Liu1, Zizhen Xu1

  • 1Department of Laboratory Medicine, College of Health Science and Technology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

PubMed
概括

这项研究引入了一种与免疫相关的基因风险模型,用于早期扩散型大B细胞淋巴瘤 (DLBCL) 的诊断和治疗指南. 经过验证的模型预测了患者的生存率,并确定了潜在的新疗法.